Background Medication-induced salivary gland dysfunction (MISGD), xerostomia (sensation
of oral dryness), and subjective sialorrhea cause significant morbidity and impair quality of …

Background Many depressed patients are not able to achieve or sustain symptom remission
despite serial treatment trials–often termed “treatment resistant depression”. A broader …

Context: Various drugs affect body weight as a side effect. Objective: We conducted this
systematic review and meta-analysis to summarize the evidence about commonly …

Because depression and painful symptoms commonly occur together, we conducted a
literature review to determine the prevalence of both conditions and the effects of …

The aim of this study was to examine the efficacy and safety of duloxetine, a balanced and
potent dual reuptake inhibitor of serotonin and norepinephrine, in the management of …

Objective: To identify drugs associated with the complaint of dry mouth. Materials and
Methods: MEDLINE was searched for papers 1980–2002 using keywords, oral, mouth …

Objective. Assess efficacy and safety of duloxetine, a selective serotonin and
norepinephrine reuptake inhibitor, on the reduction of pain severity, in patients with diabetic …

There has been an increase in the number of chronic pain clinical trials in which the
treatments being evaluated did not differ significantly from placebo in the primary efficacy …

Weight gain during antidepressant treatment can be either a sign of improvement in patients
who have weight loss as a symptom of depression or a residual symptom in patients who …

Objective To assess the efficacy and safety of duloxetine, a serotonin and norepinephrine
reuptake inhibitor, in subjects with primary fibromyalgia, with or without current major …